- Home
- LC vs OCUL Comparison
LC vs OCUL Comparison
Compare LC & OCUL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LC
- OCUL
- Stock Information
- Founded
- LC 2006
- OCUL 2006
- Country
- LC United States
- OCUL United States
- Employees
- LC N/A
- OCUL N/A
- Industry
- LC Finance: Consumer Services
- OCUL Biotechnology: Pharmaceutical Preparations
- Sector
- LC Finance
- OCUL Health Care
- Exchange
- LC Nasdaq
- OCUL Nasdaq
- Market Cap
- LC 1.5B
- OCUL 1.4B
- IPO Year
- LC 2014
- OCUL 2014
- Fundamental
- Price
- LC $14.92
- OCUL $9.16
- Analyst Decision
- LC Strong Buy
- OCUL Strong Buy
- Analyst Count
- LC 8
- OCUL 8
- Target Price
- LC $15.38
- OCUL $16.50
- AVG Volume (30 Days)
- LC 2.4M
- OCUL 889.3K
- Earning Date
- LC 10-23-2024
- OCUL 11-14-2024
- Dividend Yield
- LC N/A
- OCUL N/A
- EPS Growth
- LC N/A
- OCUL N/A
- EPS
- LC 0.46
- OCUL N/A
- Revenue
- LC $1,107,963,000.00
- OCUL $61,442,000.00
- Revenue This Year
- LC N/A
- OCUL $15.49
- Revenue Next Year
- LC $20.19
- OCUL $13.31
- P/E Ratio
- LC $32.40
- OCUL N/A
- Revenue Growth
- LC N/A
- OCUL 6.45
- 52 Week Low
- LC $5.39
- OCUL $2.05
- 52 Week High
- LC $16.16
- OCUL $11.78
- Technical
- Relative Strength Index (RSI)
- LC 59.74
- OCUL 34.86
- Support Level
- LC $15.00
- OCUL $10.46
- Resistance Level
- LC $16.16
- OCUL $11.12
- Average True Range (ATR)
- LC 0.65
- OCUL 0.57
- MACD
- LC -0.00
- OCUL -0.22
- Stochastic Oscillator
- LC 51.56
- OCUL 0.60
About LC LendingClub Corporation
LendingClub Corp is a company engaged in operating an online lending marketplace platform that connects borrowers and investors for the provision of the loan facility. It offers investors access to an asset class that has generally been closed to many investors and only available on a limited basis to institutional investors. The company through the platform offers loan products such as personal, education and patient finance, small business, and auto to interested investors. It generates a majority of the revenue from the transaction fees received from the platform's role in accepting and decisioning applications on behalf of the bank partners to enable loan originations.
About OCUL Ocular Therapeutix Inc.
Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.